Open AccessSAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Author(s) -
Manali Sapre,
Douglas Tremblay,
Amanda Leiter,
Alexander Coltoff,
Anita Geevarghese,
John Mascarhenas,
Emily J. Gallagher
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-091
Subject(s) - ruxolitinib , medicine , myelofibrosis , clinical trial , oncology , bone marrow